BUY Dr. Reddy's Laboratories Limited — Manas Jaiswal

Entry₹1,220.8Inferred
Target₹1,250
Total upside +2.39% (call closed)
Stop loss₹1,205-1.29% risk
Exit₹1,2057 Oct 2026, 12:14 pm
Stop-loss hit-1.29%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Oct 2026
5 supporting0 opposing
Supports the BUY call (5)

2 advisors have active swing BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·6 Oct · today

1 other SEBI-registered advisor has an active intraday BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Oct · today

Citi raises target for Dr Reddy's Laboratories stock to INR 1,450

NewsGoogle News·2 Oct · 4d ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade to Buy

NewsGoogle News·1 Oct · 6d ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade as margins face a test

NewsGoogle News·30 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.